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Abstract 31 
The bioaccessibility of chlorogenic acid (CGA) and caffeine in coffee silverskin extracts (CSE) 32 
and the contribution of these substances to the prophylactic effect of CSE on the pathogenesis 33 
of diabetes has not been reported. This study aimed to evaluate the bioaccessibility, 34 
bioavailability and bioactivity of CGA and caffeine alone and in CSE in the pancreas of rats 35 
treated with streptozotocin-nicotinamide (type 2 diabetes model). Metabolism of CGA and 36 
caffeine started in the gastrointestinal tract due to changes of pH taking place during digestion. 37 
Their metabolites protected pancreatic cells against the risk of diabetes. This is the first in vivo 38 
study to demonstrate a specific chemo-protective effect of CSE in pancreatic tissue, and this 39 
effect may be associated with its antioxidant capacity. Daily administration of CSE, CGA or 40 
caffeine 35 d previous to the induction of diabetes significantly reduced (p < 0.05) pancreatic 41 
oxidative stress and protein damage. 42 
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1. Introduction  63 
According to the International Diabetes Federation (IDF), type 2 diabetes mellitus (T2DM) is 64 
one of the most frequent diseases in the world, with 387 million cases in 2014 (IDF, Diabetes 65 
Atlas Group, 2015). T2DM is a very complex and multifactorial metabolic disease 66 
characterized by insulin resistance and β cell failure, leading to high blood glucose levels. 67 
Oxidative stress plays an important role in hyperglycaemia-induced pancreas injury as well as 68 
in the early events leading to the development of T2DM. Advanced glycation end-products 69 
(AGEs) increase reactive oxygen species (ROS) formation and impair antioxidant systems. 70 
Furthermore, the formation of some AGEs is induced per se under oxidative conditions 71 
(Nowotny, Jung, Höhn, Weber, & Grune, 2015). There is also evidence that antiglycative 72 
agents in foods and medicine may reduce the risk of diabetes and treat the pathology (Uribarri 73 
et al., 2015). 74 
Coffee silverskin (CS), the tegument of green coffee beans (outer layer), is the only by-product 75 
of the roasting process. Previous studies have proposed the use of coffee silverskin extracts 76 
(CSE) as a natural source of bioactive compounds, such as chlorogenic acid (CGA), caffeine, 77 
melanoidins and dietary fibre among others, with putative health benefits (del Castillo, 78 
Fernandez-Gomez, Martinez-Saez, Iriondo, & Mesa, in press). Indeed, glucoregulatory 79 
properties have recently been ascribed to CSE by-products of roasting coffee ( del Castillo, 80 
Fernandez-Gomez, Ullate, & Mesa, 2014). The antidiabetic effect of CSE has been initially 81 
associated with its capacity to inhibit the enzymatic activity of α-glucosidase and lipase taking 82 
into account in vitro results ( del Castillo, Fernandez-Gomez, Ullate, & Mesa,). 2014). CSE is 83 
also able to inhibit the formation of AGEs. The anti-AGEs capacity of CSE may be ascribed to 84 
CGA and other bioactive compounds composing the extract (Mesías et al., 2014). Fernandez-85 
Gomez et al. (2015) reported a novel antiglycoxidative  mechanism of action of CGA. 86 
Moreover, CSE may protect pancreatic tissue in vitro against oxidative stress induced by the 87 
commonly-used diabetogenic agent streptozotocin (STZ) (Fernandez-Gomez et al., in press). 88 
The antidiabetic mechanism of action of CSE in vivo should be elucidated and the present study 89 
provides some insights on that matter.  90 
Healthy effects associated with foodlargely depend on the bioaccesibility and bioavailability 91 
of their bioactive components in the organism. CSE, like other food matrices, is a complex 92 
mixture of bioactive compounds. Nowadays, the bioaccessibility of CGA and caffeine 93 
composing CSE, and therefore, their true in-vivo potential are unknown. Moreover, the 94 
contribution of CGA and caffeine to the prophylactic effect of CSE on the pathogenesis of 95 
diabetes has not been reported. This study aimed to evaluate the bioaccessibility, bioavailability 96 
and bioactivity of CGA and caffeine alone and in CSE in the pancreas of rats treated with STZ-97 
nicotinamide (NA), using phytochemomics (del Castillo, Martinez-Saez, Amigo-Benavent & 98 
Silvan, 2013b). No data on that matter have been previously published. Although CSE and 99 
coffee brews present some similarities in chemical composition they are significant different. 100 
As a consequence, the effect in health of both matrices may be very different. On the other 101 
hand, the valorisation of the coffee by-product into an antidiabetic product is of great interest 102 
and it has not been previously reported by others. The present study provides relevant data to 103 
support the interest of CSE as a functional product for diabetes and the potential of the coffee 104 
sector in bioeconomy.  105 
2. Material and Methods 106 
2.1. Chemicals  107 
Pancreatin (P-1625), α-amilase from human saliva type IX-A (A0521), 2.2′-azino-bis (3-108 
ethylbenzothiazoline-6-sulphonic acid) diammonium salt (ABTS), CGA, hippuric acid (HA) , 109 
caffeine and paraxanthine solution, formic acid, o-phthaldehyde, 2,2′-Azobis (2-110 
amidinopropane) dihydrochloride (AAPH), glutathione reductase (GR), reduced and oxidized 111 
glutathione (GSH and GSSG, respectively), NADH, NADPH, tert-butylhydroperoxide (t-112 
BOOH), 1,4-dithiothreitol (DTT) buffer, STZ and NA were purchased from Sigma Chemical 113 
(Sigma-Aldrich, St Louis, MO, USA). The other chemicals and equipment used were: Pepsin 114 
(Merck 1.07190) and Amicon® Ultra-0.5 ml centrifugal filter unit fitted with an Ultracel®-10 115 
K regenerated cellulose membrane (30 kDa cut-off) (Merck, Darmstadt, Germany), Bradford 116 
reagent for the protein assay (Bio-Rad, München, Germany), methanol (MeOH) HPLC-grade 117 
(Lab-Scan, Gliwice, Sowinskiego, Poland). Distilled water was deionized using a Milli-Q 118 
system (Millipore, Bedford, MA, USA). All other chemicals were of analytical grade. 119 
2.2. Preparation of coffee silverskin extract  120 
Arabica CSE was prepared by aqueous extraction following the procedure patented by del 121 
Castillo et al. (2013a). Brieﬂy, 50 ml of boiling water was added to 2.5 g of CS. The mixture 122 
was stirred at 4 g for 10 min, ﬁltered through no. 4 Whatman paper and freeze-dried. The 123 
powdered extracts were stored in a dark and dry place until analysis. The sample (37 mg/ml 124 
CSE solution) was filtered through a 0.45 µm pore diameter nylon membrane syringe filter 125 
(Análisis Vínicos, Ciudad Real, Spain) and diluted 100-fold with Milli-Q water and 10 µl 126 
aliquots analysed in triplicate by UPLC-MS/MS. CSE contained 19.87 ± 2.41 mg caffeine/g 127 
dry matter and 6.88 ± 1.77 mg CGA/g dry matter. 128 
2.3. Evaluation of the bioaccessibility of coffee silverskin extract  129 
2.3.1. In vitro oral gastrointestinal digestion 130 
The amount of CSE components potentially available for further uptake was determined 131 
following the procedure of  Hollebeeck, Borlon, Schneider, Larondelle, and Rogez (2013) with 132 
slight modifications. To mimic in vitro oral digestion, 1.17 g of CSE was suspended in 9 ml of 133 
Milli-Q water and the pH was adjusted to 6.9 with 1M HCl and brought to a volume of 9.98 134 
ml. α-Amilase (0.45 ml of 0.562 mg/ml in phosphate buffer) was added to each sample and 135 
incubated at 37 ºC for 5 min with constant stirring at 4 g.  For the gastric digestion step, 10 ml 136 
of Milli-Q water was added and the pH of the samples was adjusted to 2.0 with 1 M HCl. 137 
Pepsin (110 μl, 5 mg/ml in 0.1 M HCl) was added to each sample and incubated in a final 138 
volume of 22.88 ml at 37 ºC for 90 min under anaerobic conditions using an anaerobic chamber 139 
model Bactron II (Biogen, Weston, MA, USA) with constant stirring at 4 g. After this time, the 140 
pH of the samples was adjusted to 7 with 1M NaHCO3 for the intestinal digestion step. One ml 141 
of pancreatin solution (287.59 mg/ml in 0.1 M NaHCO3) was added, the final volume brought 142 
to 31.24 ml with Milli-Q water, and the mixture was incubated at 37 ºC for 150 min under 143 
anaerobic conditions. Digested samples were centrifuged at 1677 g at 4 ºC for 40 min. 144 
Enzymatic activity was stopped with liquid N2 and supernatants were freeze-dried and stored 145 
under dark, dry conditions at 4 ºC until analysis. The digestion of CSE was also carried out 146 
under the same conditions without adding the enzymes to gain insight into the effect of the pH 147 
in CGA and caffeine metabolism. Digestion experiments were carried out in triplicate. 148 
2.3.2. Chemical composition of digested and non-digested coffee silverskin extract  149 
Total phenolic content (TPC) was determined using the Folin-Ciocalteu’s colorimetric assay 150 
(Singleton, Orthofer, & Lamuela-Raventós, 1999) adapted to a microplate reader. Briefly, CSE 151 
prepared at 2 mg/ml was used. Ten µl of the sample was combined with 200 μl of Folin reagent 152 
(0.017% (v/v)) and 50 μl of NaHCO3 (30 mg/ml). The 96-well plate was incubated in darkness 153 
at room temperature for 2 h and was read at 725 nm using a BioTek PowerWave™ XS 154 
(Winoski, VT, USA) microplate reader. Calibration curves were constructed using a standard 155 
solution of CGA (0.1-0.8 mg/ml). Samples were analyzed in triplicate and results expressed as 156 
mg of CGA equivalents per g of CSE (mg CGA /g CSE). 157 
The contents of CGA and caffeine in the CSE and their digested products was analyzed by 158 
capillary zone electrophoresis (CZE) as described by del  ) del Castillo, Ames, and Gordon 159 
(2002). Previously, the digested CSE (10 mg of extract/ml) was filtered through 0.2 μm nylon 160 
filters (Symta, Madrid, Spain). Determinations were carried out in an Agilent G1600 A (Santa 161 
Clara, CA, USA) capillary electrophoresis instrument equipped with ChemStation software 162 
and a diode array detector (DAD). CZE was performed in an uncoated fused 48.5 cm long silica 163 
capillary (40 cm to the detector) with an internal diameter of 50 μm and a x3 bubble cell. The 164 
other analysis conditions were as follows: 50 mM sodium borate buffer (pH 9.5), 20 kV 165 
voltage, 25 ºC temperature and the injection was at 50 mbar for 5 s. Electropherograms (e-166 
grams) were monitored at 200 and 280 nm for CGA and caffeine, respectively; and spectra 167 
collected from 190 to 600 nm. The capillary was conditioned after running each sample by 168 
flushing with 0.1 M NaOH and buffer for 3 min. CGA (0.15-9 mM) and caffeine (0.15-10 mM) 169 
calibration curves were used as standards for identification and quantification. Samples were 170 
analyzed in triplicate and results were expressed as mg of CGA or caffeine/g CSE. 171 
2.3.3. Antioxidant capacity of digested and non-digested coffee silverskin extract  172 
Antioxidant capacity was determined by the ABTS and ORACFL assays, respectively. The 173 
ABTS assay was carried out according to  Oki, Nagai, and Yoshinaga (2006). ABTS+ was 174 
produced by reacting 7 mM ABTS and 2.45 mM potassium persulfate (final concentration in 175 
10 ml of water). The mixture was incubated in the dark at room temperature for 16 h before 176 
use. The aqueous ABTS+ solution was diluted 1:75 (v/v) with 5 mM phosphate buffer (pH 7.4) 177 
obtaining an absorbance value of 0.7 ± 0.02 at 734 nm. Thirty microlitres of sample (0.2 mg of 178 
non-digested CSE /ml or 0.2 mg of digested CSE/ml) or standard and 270 µl of ABTS+ 179 
working solution were placed in each well. Absorbance readings were recorded in a microplate 180 
reader at 734 nm every minute. A standard calibration curve was constructed using Trolox 181 
(0.01-0.25 mM), and results were expressed as µmoles of Trolox equivalents (TE)/g of CSE. 182 
Another calibration curve using CGA, the major phenolic compound in coffee, was constructed 183 
(0.05-0.25 mM), and results were expressed as µmoles of CGA equivalents (CGA)/g of CSE. 184 
Samples were analyzed in triplicate. 185 
An aliquot of non-digested CSE (10 mg/ml) was subjected to fractionation using an Amicon® 186 
Ultra 0.5 ml centrifugal filter unit fitted with an Ultracel®-10K regenerated cellulose membrane 187 
(10 kDa cut-off) (Merck Millipore, Darmstadt, Germany). The antioxidant capacity of low (< 188 
10 kDa) and high (≥ 10 kDa) molecular weight fractions was also analysed using the ABTS•+ 189 
assay. 190 
The ORACFL assay was performed following the procedure described by Huang, Ou, 191 
Hampsch-Woodill, Flanagan, and Prior (2002). Briefly, 25 μl of sample of the appropriate 192 
dilution or standard were added to a 96-well microplate followed by the addition of 150 μl of 193 
fluorescein work solution (8.5 x 10-5 mM) prepared in 75 mM phosphate buffer (pH 7.4). The 194 
Biotek Synergy™ HT microplate reader (Biotek Instruments, Highland Park, Winooski, VT, 195 
USA) was programmed to incubate the plate at 37 ºC and add 30 μl of AAPH solution (153 196 
mM in phosphate buffer) as a peroxyl radical generator. Fluorescence was read with excitation 197 
at 485 nm and emission at 528 nm every two minutes for 90 min. A blank consisting of 198 
fluorescein, AAPH and phosphate buffer was also included. Calibration curves of Trolox (6.25-199 
50 μM) and CGA (3.12-25 μM) were constructed. Standard calibration curves were composed 200 
by plotting the net area under the curve (AUC) as a function of Trolox or CGA concentration. 201 
ORACFL values were expressed as µmoles TE/g of CSE and as µmoles CGA/g of CSE. 202 
2.4. Animals and the experimental design (ARRIVE guidelines) 203 
The experimental protocols were approved by the Ethical Committee for the Use of Laboratory 204 
Animals of the UGR, Universidad de Granada, Campus de la Cartuja, GR, Spain (CEEA: 2010-205 
287).  206 
CSE doses administrated to the animals in vivo provided 0.150 and 0.434 mg/d of CGA and 207 
caffeine, respectively. CGA and caffeine dose selection was based on moderate coffee 208 
consumption (3 cups a day) in adults (del Castillo, Ames & Gordon, 2002; Heckman, Weil & 209 
Gonzalez de Mejia, 2010), and the CSE dose was limited by its caffeine content (max. 300 210 
mg/day).  211 
2.4.1. Evaluation of the bioavailability of coffee silverskin extract   212 
Twelve 6-week-old male Wistar rats (ENVIGO, Alconbury, United Kingdom) were housed 213 
singly in metabolic cages with free access to standard food (2014S Teklad, ENVIGO, 214 
Alconbury, United Kingdom) and water ad libidum. Food and water intake were measured by 215 
subtracting the remaining amount of food and water in the containers from the total amount 216 
given the day before, during the bioavailability study. Animals were divided into four groups 217 
(n = 4): rats treated with CSE, rats treated with CGA, rats treated with caffeine and untreated 218 
rats (control).  At 8:00 in the morning, the CSE group received one single dose of CSE 219 
(containing 2.2 mg caffeine/kg body weight; 0.8 mg CGA/kg body weight), the CGA group 220 
received pure CGA (1.5 mg CGA/kg body weight) and the caffeine group received pure 221 
caffeine (5 mg/kg body weight). Urine samples were then serially collected from treated rats 222 
every hour for 6 hours, then every 2 h up to 10 h and finally after 24 h. Urine samples were 223 
collected from untreated rats every 24 hours as a control. Samples were stored at -80 °C until 224 
analysis. After 3 days of clearance, the bioavailability experiments were repeated with the same 225 
animals. 226 
Urinary creatinine was measured with the creatinine quantitative test kit (SPINREACT, 227 
Gerona, Spain) based on the Jaffe reaction, as previously described by Murray (1984).  228 
CGA, caffeine and related compounds, HA and paraxanthine were determined by UPLC-229 
MS/MS. Urine samples were defrosted, centrifuged at 10481 g for 10 min at 4 °C and 230 
supernatants were filtered using a 0.45 µm pore-size nylon membrane syringe filter (Análisis 231 
Vínicos, Ciudad Real, Spain). Aliquots (10 µl) were analysed in triplicate using an Accela 232 
liquid chromatograph (Thermo Scientific, San Jose, CA, USA) equipped with a DAD and an 233 
autosampler. The chromatograph was coupled to a TSQ TSQ Quantum (Thermo Scientific) 234 
triple quadrupole analyzer via an electrospray ionization (ESI) interface. Xcalibur software 235 
(Thermo Scientific) was used for data storage and evaluation. Analytical conditions consisted 236 
of a ZORBAX SB-C18 (50 mm × 2.1 mm and 1.8 μm of particle diameter) column (Thermo 237 
Scientific) using 1% (v/v) formic acid in methanol and 1% (v/v) formic acid in Milli-Q water 238 
as A and B mobile phases, respectively. Elution was carried out according to the following 239 
gradient: 0 min, 95% B; 0.35 min, 95% B; 7 min, 80% B; 9.5 min, 5% B; 10 min; 95% B; 15 240 
min, 95% B. Optimum flow rate was 0.3 ml/min, whereas the injection volume was 10 μl. The 241 
DAD recorded the spectra from 200 to 450 nm. Column and autosampler compartments were 242 
kept at 30 °C and 4 °C, respectively. The mass spectrometer was operated in the positive ESI 243 
mode to quantify caffeine and paraxanthine and in the negative ESI mode to quantify CGA and 244 
HA. Spray voltage and capillary temperature were set at 3500 V and 250 °C, respectively. 245 
Nitrogen was used as a sheath and auxiliary gas at pressures of 40 and 20 arbitrary units, 246 
respectively. Ion sweep gas pressure was 2 units and collision gas (Ar) pressure was 190 mPa. 247 
Scan width and scan time were fixed at 0.020 (m/z) and 0.100 s, respectively, and the system 248 
was operated in selected reaction monitoring (SRM). SRM parameters were optimized by 249 
direct infusion of standards. Two transition ions were monitored for identification but only the 250 
most intense one for each precursor ion was used for quantification. Parent ([M-H]-) and 251 
product ions for CGA and HA were m/z 353.2  191.1 and m/z 178.3  134.3, respectively, 252 
whereas parent ([M-H]+) and product ions for caffeine and paraxanthine were m/z 195.1  253 
138.2 and m/z 181.1  124.2, respectively.  254 
2.4.2. Evaluation of the bioactivity of coffee silverskin extract in the pancreas of 255 
streptozotocin-nicotinamide diabetic rats 256 
Thirty-two 6-week-old male Wistar rats (ENVIGO, Alconbury, United Kingdom) were divided 257 
into four groups (n = 8) paired by weight (average weight per group was 194 ± 2 g). Rats were 258 
maintained at 23 ± 1 ˚C and 55 ± 5 % relative humidity on a 12:12-hour light-dark cycle with 259 
free access to standard food (2014S Teklad, ENVIGO, Alconbury, United Kingdom) and water 260 
ad libidum. Food and water intake were measured by subtracting the remaining amount of food 261 
and water in the containers from the total amount given the day before, during the experimental 262 
time. The rats in groups 1, 2 and 3 were supplemented by gastric gavage with CSE (2.2 mg 263 
caffeine/kg body weight, 0.8 mg CGA/ kg body weight), pure CGA (1.5 mg CGA/kg body 264 
weight) and pure caffeine (5 mg caffeine /kg body weight) dissolved in 1 ml of sterile water, 265 
respectively, every day for a total of 42 days. The fourth group (the STZ group) was treated 266 
similarly with sterile water. At day 35, all rats were injected with 200 mg/kg body weight of 267 
NA dissolved in saline buffer, and 15 min later T2DM was induced by the intraperitoneal 268 
injection of 60 mg/kg body weight of STZ dissolved in cold 0.1 M citrate buffer (pH 4.5) 269 
immediately before use,  according to Masiello et al. (1998). The order in which the animals 270 
were injected was randomized among the groups. Blood samples were obtained from the tail 271 
vein and glucose levels (mg/dl) were determined after T2DM induction every day for six days 272 
using a glucometer (FreeStyle Lite®, Abbott Laboratories). Rats were considered diabetic when 273 
blood glucose levels were above 200 mg/dl. An additional healthy control group (n = 8) was 274 
also included in the experiment.  275 
At day 42, overnight-fasting blood glucose was measured using a glucometer. The fasting rats 276 
were then anaesthetised with Ketamine-Xylazine (1 ml/kg body weight and 0.5 ml/kg body 277 
weight, respectively) and sacrificed. The pancreas was removed promptly, weighed, divided 278 
into three parts and stored at −80 °C until required.  279 
Glutathione peroxidase (GPx) and GR activity were determined in pancreas homogenates as 280 
described by Rodríguez-Ramiro, Martín, Ramos, Bravo, and Goya (2011). Thus, pancreatic 281 
tissues were homogenized (1:5 w/v) in 0.25 M Tris, 0.2 M sucrose and 5 mM DTT buffer pH 282 
7.4 and centrifuged at 3000 g for 15 min. Determination of GPx activity was based on the 283 
oxidation of GSH by GPx, using t-BOOH as a substrate, coupled to the disappearance of 284 
NADPH catalysed by GR which reduced GSSG. GR activity was determined based on the 285 
decrease in absorbance due to the oxidation of NADPH used in the reduction of GSSG. Total 286 
pancreatic protein content was measured by the Bradford method (Bradford, 1976). 287 
GSH concentration was evaluated using the previously described fluorometric assay ( 288 
Rodríguez-Ramiro, Martín, Ramos, Bravo, & Goya, 2011). This method takes advantage of 289 
the reaction of GSH with o-phthaldehyde at pH 8.0. Pancreatic tissues were homogenized (1:20 290 
w/v) in 50 mM phosphate buffer pH 7.0, and proteins were precipitated with 5% trichloroacetic 291 
acid and then centrifuged for 30 min at 10.000 g. Fluorescence was measured at an emission 292 
wavelength of 460 nm and an excitation wavelength of 340 nm. Results were interpolated in a 293 
GSH standard curve (5-1000 ng) and expressed as nmol/mg protein. 294 
Pancreatic protein oxidation was measured as carbonyl groups content according to Granado-295 
Serrano, Martín, Bravo, Goya, and Ramos (2009). Pancreatic tissues were homogenized (1:5 296 
w/v) in 0.25 M Tris, 0.2 M sucrose and 5 mM DTT buffer pH 7.4 and centrifuged at 3000 g 297 
for 15 min. Absorbance was measured at 360 nm, and carbonyl content was expressed as 298 
nmol/mg protein using an extinction coefficient of 22000 nM/cm. Total pancreatic protein 299 
content was measured by the Bradford reagent. 300 
2.5. Data analysis  301 
SPSS program version 22.0 was used for statistical analyses. Comparisons of excretion 302 
pharmacokinetic parameters between treatments were done by Student’s T-test. Kolmogorov-303 
Smirnov test and Q-Q graphics were used to test normality for the distribution of values by 304 
group of treatment. The normality assumption was met for all data by group of treatment. Prior 305 
to statistical analysis, all data were tested for homogeneity of variances using the Levene’s test 306 
in order to determine the appropriate statistical technique to be used for comparing means 307 
between groups of treatmentsTo compare TPC, CGA and caffeine content of non-digested 308 
CSE, digested CSE and CSE digested control (absence of enzymes) multiple comparisons were 309 
carried out using one-way ANOVA followed by Bonferroni test when variances were 310 
homogeneous or by Games-Howell test when variances were not. Antioxidant capacity 311 
between CSE non-digested and CSE digested were analyzed with a T-test for dependent 312 
samples, using the adjustment for heterogeneous variances when necessary. Maximum 313 
concentration (Cmax), AUC and the time required to reach maximum concentration (Tmax) of 314 
metabolites in urine was evaluated using Microsoft Excel functions (Usansky, Desai, & Tang-315 
Liu, 2010). To compare pharmacokinetic parameters of hippuric acid a multiple comparisons, 316 
one-way ANOVA technique with the application of the Snedecor's F-test was carried out 317 
followed by a Sidak posthoc test when variances were homogeneous (AUC and Tmax) or by the  318 
T3 Dunnet posthoc test when variances were not homogeneous (Cmax). To compare 319 
pharmacokinetic parameters of caffeine and paraxanthine, a T-test for independent samples 320 
were performed, using the adjustment for heterogeneity when necessary. Carbonyl content, 321 
GSH, GR and GPx activity comparisons between treatments were analyzed by one-way 322 
ANOVA followed by Bonferroni test when variances were homogeneous or by T3-Dunnet 323 
posthoc test when variances were not. The level of significance was p < 0.05 except in the case 324 
of carbonyl content (p < 0.1). 325 
3. Results 326 
3.1. In vitro bioaccessibility of the bioactive compounds of coffee silverskin extract 327 
TPC and CGA and caffeine levels of 46.65 mg/g, 13.33 mg/g and 44.64 mg/g were detected in 328 
CSE, respectively. Overall antioxidant capacity values of 397 and 358 µmol CGA/g 329 
(corresponding to 427 and 816 of µmol TE/g) were obtained for scavenging and hydrogen 330 
donating capacities in CSE, respectively (Table 1). The antioxidant capacity of low molecular 331 
weight compounds (<10 kDa) was 220 µmol CGA/g, while the antioxidant capacity of the 332 
fraction containing high molecular weight compounds (≥10 kDa) was 110 µmol CGA/g.  333 
In vitro digestion of CSE decreased concentrations of caffeine (25%), TPC (40%) and CGA 334 
(82%). The overall antioxidant capacity of CSE as measured by ABTS and ORAC decreased 335 
by 15% and 50%, respectively (Table 1).  336 
To evaluate the effect of changes in pH during digestion on the degradation of bioactive 337 
compounds, a digestion in the absence of digestive enzymes was performed. Changes in pH 338 
decreased TPC and CGA content by 38% and 83%, respectively, while caffeine content only 339 
decreased by 15%.   340 
CSE can provide bioaccessible amounts of bioactive compounds such as TPC (79.26 µmol/g), 341 
CGA (6.86 µmol/g) and caffeine (172.37 µmol/g). Digests presented antioxidant capacities of 342 
337 µmol/g and 179 µmol/g by ABTS and ORAC assays, respectively.  343 
3.2. Metabolism of the bioactive compounds of coffee silverskin extract 344 
Figure 1 shows the kinetics of the urinary excretion of CGA, caffeine and their metabolites. 345 
Urinary pharmacokinetic parameters of these compounds after CSE, caffeine and CGA 346 
consumption are presented in Table 2. Intact CGA was not found in the urine of rats fed with 347 
CSE (containing 0.150 mg of CGA/day), CGA (0.293 mg of CGA/day) or caffeine. The 348 
baseline value of HA in urine excretion was set at 431.7 µmol/mmol creatinine and was 349 
obtained by measuring HA in the 24 h urine of the animals before administering the products.  350 
HA excretion was the greatest after the ingestion of CGA, reaching a peak in the 0-2 h interval, 351 
and AUC was significantly higher than that found after the intake of CSE and caffeine (p < 352 
0.001 and p = 0.017, respectively) (Table 2). The maximum concentration of HA in urine 353 
(1346.9 mmol/µmol creatinine) was found 1.6 h after CGA consumption, which was higher 354 
than the maximum HA concentrations found in urine after CSE intake (p < 0.008) (Figure 1A 355 
and Table 2). 356 
Excretion of caffeine and its metabolite paraxanthine were not detected in the urine of CGA 357 
treated rats. Non-metabolized caffeine in urine excretion  after the consumption of pure 358 
caffeine was higher than that found after treatment with CSE (p < 0.001 for AUC and p = 0.001 359 
for Cmax) (Figure 1B and Table 2). Urinary excretion of caffeine was almost completed before 360 
12 h in rats treated with caffeine or  with the CSE (Figure 1B). 361 
Urinary paraxanthine excretion after consumption of pure caffeine tended to be higher  than 362 
that found after the intake of CSE (p = 0.056 for AUC and p = 0.050 for Cmax) (Figure 1C and 363 
Table 2).In this case, paraxanthine needed 24 h to be completely excreted in urine after the 364 
intake of both CSE and caffeine (Figure 1C). 365 
Both studied compounds were metabolized. Free CGA was not detected in urine and caffeine 366 
was metabolized to paraxanthine.  367 
3.3. Bioactivity of coffee silverskin extract in the pancreas of streptozotocin-368 
nicotinamide diabetic rats 369 
The effect of the CSE, CGA and caffeine treatments on oxidative stress biomarkers in the 370 
pancreas of diabetic rats is shown in Figure 2. Rats were considered diabetic when blood 371 
glucose levels were above 200 mg/dl. The STZ-NA treatment caused significant oxidation (p 372 
< 0.1) of pancreatic proteins by increasing their carbonyl groups (Figure 2A). On the contrary, 373 
animals pre-treated with CGA or caffeine for 35 d significantly prevented (p < 0.1) oxidative 374 
protein damage induced by STZ. Protein carbonyl content decreased by 24% and 22% in the 375 
pancreas of diabetic rats treated with CGA and caffeine, respectively. However, CSE did not 376 
reduce the rate of protein oxidation induced by the toxic agent. GSH content in the pancreas of 377 
T2DM rats decreased significantly (p < 0.05) (Figure 2B), and pre-treatment with CSE and 378 
CGA significantly reduced (p < 0.05) GSH depletion in the pancreas of diabetic rats. Untreated 379 
rats and those treated with CSE and CGA showed similar pancreatic GSH values (p > 0.05). 380 
GPX and GR values of all animals were of the same order of magnitude (p > 0.05) (Figure 2C).  381 
The physiological concentrations of the bioactive compounds forming CSE were able to protect 382 
pancreatic cells against oxidative stress produced by the diabetogenic agent STZ. 383 
4. Discussion 384 
This is the first study assessing the role of the gastrointestinal digestion on the bioaccessibility 385 
of CSE bioactive compounds and its remnant overall antioxidant capacity. 386 
TPC values found in CSE are in agreement with those described by other authors (Martinez-387 
Saez et al., 2014; Mesías et al., 2014). Slightly higher CGA and caffeine concentrations were 388 
found in CSE than in CS raw material (4.31 mg CGA/g and 10 mg caffeine/g) using a similar 389 
analytical method (Bresciani, Calani, Bruni, Brighenti, & Del Rio, 2014). Results suggest that 390 
aqueous extraction increases the bioaccessibility of the bioactive compounds present in the 391 
plant matrix. Values of overall antioxidant capacity also agree with those reported by Mesías 392 
et al. (2014). The highlighted chemical composition of CSE suggests that it could be a good 393 
source of bioactive compounds with putative healthy benefits (del Castillo, Fernandez-Gomez, 394 
Martinez-Saez, Iriondo, & Mesa, in press).  395 
Our results indicate that in vitro digestion affected the composition of CSE reducing the 396 
bioaccessibility of TPC, CGA and caffeine. However, digests presented antioxidant capacity 397 
suggesting that antioxidants remained bioaccessible after the digestion process. The release of 398 
compounds from the plant matrix depends on the chemical form and the properties of nutrients 399 
and phytochemicals (Holst & Williamson, 2008). TPC and CGA contents were significantly 400 
decreased (p < 0.05) by the digestion processes (data not shown). Since this decrease was 401 
observed in the absence of digestive enzymes, it may be associated with changes in pH taking 402 
place during in vitro digestion. Several studies have shown that the bioaccessibility of TPC in 403 
different food matrixes was lower than that found for isolated polyphenols. Podio et al. (2015) 404 
observed a 5-fold lower TPC content in digested coffees than in native instant coffees. Campos-405 
Vega et al. (2015) reported a considerable reduction of TPC (91%) in spent coffee grounds. 406 
Akillioglu and Karakaya (2010) showed that the bioaccessibility of TPC ranged from 19% to 407 
39% in bean varieties. Phenolic compounds are less bioaccessible partly due to the presence of 408 
dietary fiber in the plant matrix (Palafox-Carlos, Ayala-Zavala, & González-Aguilar, 2011). 409 
CSE contains high amounts of dietary fiber (362 mg/g) which affect the release of TPC in the 410 
digestion process. Hydroxycinnamic acid derivatives constitute the main phenolic component 411 
of CS (Bresciani, Calani, Bruni, Brighenti, & Del Rio, 2014).Vallejo, Gil-Izauierdo, Pérez 412 
Vicente, and García-Viguera (2004) observed an 87% decrease in CGA after intestinal 413 
digestion. Previous studies have suggested that a pH value of 7.5 and bile salts could contribute 414 
to lower CGA.  Bermúdez-Soto, Tomás-Barberán, and García-Conesa (2007) reported a minor 415 
decrease in CGA (5%) in chokeberry extract due to the pH of intestinal digestion (pH 7.5). 416 
However, a bioaccessibility study of CGAs in spent coffee grounds showed a total recovery of 417 
this compound after digestion (Monente et al., 2015). These differences in CGA release suggest 418 
that bioaccessibility is also affected by the plant matrix.  419 
In agreement with the data on TPC and CGAs, overall antioxidant capacity also decreased after 420 
in vitro gastrointestinal digestion. The main antioxidant compounds reported in CSE are CGAs, 421 
melanoidins and antioxidant fiber (Fernandez-Gomez, Martinez-Saez, Iriondo, & Mesa, in 422 
press). According to our data, low molecular weight compounds (CGAs, other phenols and 423 
caffeine among others) seem to make a greater contribution to the in vitro overall antioxidant 424 
capacity of CSE than the high molecular weight fraction (melanoidins, proteins and antioxidant 425 
fiber).  Rice-Evans, Miller and Paganga (1996) found that CGA antioxidant activity is related 426 
to the CH=CH-COOH group, which ensures greater H-donating ability and radical 427 
stabilization. Caffeine effectively reacts with the hydroxyl radical (OH·) and caffeine-derived 428 
oxygen-centered radicals are formed in the reaction between caffeine and OH (Shi, Dalal, & 429 
Jain, 1991). In this sense, Pellegrini et al. (2003) found a decrease of ∼25–30% in the 430 
antioxidant capacity of espresso coffee when the caffeine was removed.  431 
The greatest part of the CGA ingested by rats is hydrolyzed to caffeic acid and quinic acid, and 432 
further metabolized by gut microbiota into various aromatic acid metabolites including m-433 
coumaric acid and derivatives of phenylpropionic and benzoic acids (Figure 3) (Gonthier, 434 
Verny, Besson, Rémésy, & Scalbert, 2003). Previous studies found that HA, a benzoic acid, 435 
was the major CGA-derived metabolite observed in urine and plasma after the ingestion of 436 
pure CGA or CGA from a food matrix (Gonthier, Verny, Besson, Rémésy, & Scalbert, 2003; 437 
Mulder, Rietveld, & van Amelsvoort, 2005). We found amounts of HA in urine of 1346.9 438 
mmol/µmol creatinine after the intake of a single dose of 0.825 µmol CGA. Urine HA 439 
concentration after the intake of CSE containing 0.424 µmol CGA (447.9 mmol/µmol 440 
creatinine) was of the same order of magnitude as basal values (431.7 mmol/µmol creatinine). 441 
These results are in agreement with the low bioaccessibility observed for the CGA present in 442 
CSE. The metabolic fate of CGAs ingested as a pure compound or present in coffee has been 443 
previously investigated in rats (Choudhury, Srai, Debnam, & Rice-Evans, 1999; Gonthier, 444 
Verny, Besson, Rémésy, & Scalbert, 2003) and humans (Monteiro, Farah, Perrone, Trugo, & 445 
Donangelo, 2007; Stalmach, Williamson, & Crozier, 2014). Farah, Monteiro, Donangelo, and 446 
Lafay (2008) reported high bioavailability of CGAs present in a green coffee extract in humans. 447 
In this study, we did not detect intact CGA in urine after oral dosing of CGA and CSE. Results 448 
suggest that CGA was absorbed and metabolized into different compounds to those tested in 449 
the present study. In accordance with our findings, several authors failed to detect CGA in the 450 
plasma or urine of rats and humans fed pure CGA or CGA-containing foods (Booth, Emerson, 451 
Jones, & Deeds, 1957; Choudhury, Srai, Debnam, & Rice Evans, 1999; Azuma et al., 2000; 452 
Nardini, Cirillo, Natella, & Scaccini, 2002; Stalmach, Williamson, & Crozier, 2014). 453 
CSE is also a good source of caffeine (1,3,7-trimethylxanthine). Methylxanthines are 454 
extensively absorbed in the gastrointestinal tract and metabolized in the liver to yield 455 
methylxanthine derivatives and methyluric acids as the main metabolites, which are ﬁnally 456 
excreted in urine (Figure 3) (Martínez-López et al., 2014). Paraxanthine (1,7 dimethylxanthine) 457 
is the main metabolite of caffeine biotransformation found in plasma and urine after caffeine 458 
intake (Arnaud, 2011). The pharmacokinetics of caffeine and paraxanthine excretion were 459 
evaluated after the consumption of 5.026 µmol pure caffeine and CSE containing 2.211 µmol 460 
caffeine. Caffeine was present in the urine of both groups of rats, which is in agreement with 461 
other studies that described incomplete biotransformation in humans (Bonati et al., 1982; 462 
Rodopoulos, Wisén, & Norman, 1995). According to CSE composition, the lower consumption 463 
of caffeine was in line with the lower excretion observed for this compound and its metabolite 464 
paraxanthine. These results are in agreement with previous findings of dose-dependent 465 
metabolism and the excretion of caffeine in humans (Martínez-López et al., 2014). Therefore, 466 
our data showed that the caffeine present in CSE is bioavailable, partially metabolized, and 467 
rapidly excreted.  468 
The in vivo effect of CGA, caffeine and CSE on the prevention of oxidative damage in the 469 
pancreas of STZ-NA-induced T2DM rats was also evaluated. The cytotoxic action of STZ is 470 
associated with the generation of ROS and consequent β-cell destruction and suppression of 471 
insulin secretion (Szkudelski, 2001). Antioxidants are able to prevent pancreatic islets damage 472 
induced by STZ (Fernandez-Alvarez et al., 2004). Consequently, natural antioxidants may be 473 
considered promising candidates for the prevention or co-treatment of diabetes. In the present 474 
study, the administration of STZ to the animals produced a decrease in GSH and an increase in 475 
GR activity (p = 0.173), while GPx activity remained unaltered in pancreas antioxidant defense. 476 
This indicates that the depletion of GSH may induce GR activity but this induction is not 477 
enough to regenerate the basal GSH concentration. Protein oxidation was significant (p < 0.1) 478 
in the pancreas of STZ induced T2DM rats. Interestingly, the daily administration of CSE, 479 
CGA or caffeine 35 d previous to the induction of diabetes significantly prevented (p < 0.05) 480 
pancreatic oxidative stress. Treatments with CGA and caffeine significantly inhibited cellular 481 
protein damage. In vitro studies have shown that CGA (Ahn et al., 2014; Deng et al., 2013; 482 
Nam et al., 2015) and caffeine (Chen, Yu, Shen, Xia, & Xu, 2015) protect pancreatic β-cells 483 
from the oxidative stress damage caused by free radicals. Furthermore, in vivo studies have 484 
demonstrated that CGA (Karthikesan, Pari, & Menon, 2010) and caffeine (Abunasef, Amin, & 485 
Abdel-hamid, 2014; Kagami, Morita, Onda, Hirano, & Oka, 2008) could also prevent STZ-486 
induced oxidative stress and protect β-cells in vivo. The present study is the first to demonstrate 487 
a specific chemo-protective effect of CSE on pancreas tissue, possibly associated to its 488 
antioxidant capacity. 489 
In conclusion, the present study provides, for the first time, information on the bioaccessibility, 490 
metabolism and in vivo bioactivity of bioactive compounds present in CSE. The 491 
bioaccessibility of CGA and caffeine was affected by changes in pH during digestion. CGA 492 
(0.91 µmol) and caffeine (5.53 µmol) were metabolized and protected pancreatic cells against 493 
the oxidative stress induced by the diabetogenic agent. 494 
 495 
 496 
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Figure captions 701 
 702 
Figure 1. Kinetics of the urinary excretion of hippuric acid (A), caffeine (B) and paraxanthine 703 
(C) after consumption of CSE (2.2 mg caffeine/kg body weight, 0.8 mg CGA/ kg body weight), 704 
CGA (1.5 mg/kg body weight) and caffeine (5 mg/kg body weight). Results represent the 705 
concentration (µmol/mmol creatinine) as mean (n=7) ± SEM. CGA, chlorogenic acid; CSE, 706 
coffee silverskin extract. 707 
 708 
 709 
 710 
 711 
 712 
 713 
 714 
 715 
 716 
 717 
Figure 2. Effect of CSE, CGA and caffeine on oxidative status in pancreatic tissues of STZ-718 
NA induced diabetic rats. C, untreated healthy control rats; STZ, rats treated with STZ (60 719 
mg/kg body weight) and NA (200 mg/kg body weight); CSE, rats treated with STZ-NA and 720 
CSE (2.2 mg caffeine/kg body weight, 0.8 mg CGA/ kg body weight); CGA, rats treated with 721 
STZ-NA and 1.5 mg CGA/kg body weight; Caffeine, rats treated with STZ-NA and 5 mg 722 
caffeine/kg body weight; (A) GSH levels (p < 0.05, (B) GR and GPx activities (p < 0.05) and  723 
(C) Carbonyl groups production (p < 0.1) were evaluated. Data represent means ± SEM (n=8). 724 
Different letters denote statistically significant differences referred above in brackets. CGA, 725 
chlorogenic acid; CSE, coffee silverskin extract; NA, nicotinamide; STZ, streptozotocin.  726 
 727 
 728 
 729 
 730 
 731 
 732 
Figure 3. Simplified scheme of CGA and caffeine metabolism studied in the present study. 733 
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 735 
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 737 
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 741 
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 744 
 745 
 746 
 747 
Table 1. Antioxidant capacity (µmol CGA/g) of non-digested and digested CSE.  748 
 749 
 750 
 751 
 752 
 753 
 754 
 755 
 756 
 757 
 758 
 759 
 760 
 761 
 762 
 763 
 764 
 765 
 766 
 767 
Sample ABTS ORACFL 
CSE non-digested  397 ± 17
a
 358 ± 25
a
 
CSE digested 337 ± 26b 179 ± 13b 
Results are expressed as mean ± SD for n = 3. Different 
letters in the same column indicate significant differences 
(p < 0.05). CGA, chlorogenic acid; CSE, coffee silverskin 
extract.  
 768 
Table 2. Pharmacokinetic parameters (Cmax, AUC and Tmax) of metabolites detected in urine 769 
after treatments consumption with CSE (2.2 mg caffeine/kg body weight, 0.8 mg CGA/kg body 770 
weight), CGA (1.5 mg CGA/kg body weight); and caffeine (5 mg caffeine/kg body weight).  771 
Metabolite Parameters CSE 
 
CGA Caffeine 
Cmax 
(mmol/µmol) 
447.9 ± 53.0
a
 1346.9 ± 274.9
b
 782.6 ± 104.9
a,b
 
Tmax 
(h) 
0.8 ± 0.4a 1.6± 0.3 a 1.4± 0.4 a 
AUC 
(mmol/µmol·h) 
3727.0 ± 584.5
a
 13842.7 ± 2182.8
b
 7369.1 ± 1171.8
a
 
 
    
Cmax 
(mmol/µmol) 
3.3 ± 1.1
a
 nd 28.88 ± 4.6
b
 
Tmax 
(h) 
1.8 ± 0.4a
 
 
 
2.50 ± 0.5a 
AUC 
(mmol/µmol·h) 
14.8 ± 5.6
a
 
 
136.66 ± 17.7
b
 
 
    
Cmax 
(mmol/µmol) 
10.7 ± 2.7
a
 nd 22.4 ± 4.2
a
 
Tmax 
(h) 
5.5± 1.6a 
 
4.62 ± 0.6a 
AUC 
(mmol/µmol·h) 
125.3 ± 34.7
a
 
 
265.56 ± 55.8
a
 
Values represent mean ± SEM, n=7. Different letters in the same row indicate significant 772 
differences between treatments (p < 0.05). AUC, area under the curve; Cmax, maximum 773 
concentration reached; CGA, chlorogenic acid; CSE, coffee silverskin extract; n.d., not 774 
detected, Tmax, time to reach;  775 
 776 
